NCT04255992View on ClinicalTrials.gov

Short Term Cardiovascular Effects and Oxidative Status of Calcium and Vitamin D Supplementation of Postmenopausal Hypertensive Blacks Women

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
HypertensionPostmenopausal Disorder
Interventions
DIETARY_SUPPLEMENT

Calcium Arm

1000 mg Calcium tablet / day will be added to the usual treatment for each patient for a period of 8 weeks.

DIETARY_SUPPLEMENT

Vitamin D/Calcium

1000 mg/800UI of the association Vitamin D/Calcium tablet / day will be added to the usual treatment for each patient for a period of 8 weeks.

Trial Locations (1)

Unknown

Yaounde Central Hospital, Cardiology department, Yaoundé

All Listed Sponsors
lead

Yaounde Central Hospital

OTHER_GOV

NCT04255992 - Short Term Cardiovascular Effects and Oxidative Status of Calcium and Vitamin D Supplementation of Postmenopausal Hypertensive Blacks Women | Biotech Hunter | Biotech Hunter